SCHEMBL21273360

SCHEMBL21273360

Cn1ncc2c(Br)c([N+](=O)[O-])ccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 2/20 0.38
KDM4E B2RXH2 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CREBBP Q92793 1/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
ALDH1A1 P00352 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
GAA P10253 1/20 0.36
MITF O75030 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PKM P14618 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30448079 1.00 MAPT (0.38) MAPTLMNAHTTKDM4ENPSR1
SCHEMBL23536385 0.81 TDP1 (0.43) MAPTLMNAHTTKDM4ENPSR1
SCHEMBL31339761 0.81 HTT (0.40) MAPTLMNAHTTKDM4ENPSR1
SCHEMBL25428025 0.81 CREBBP (0.35) MAPTLMNAHTTKDM4ENPSR1
SCHEMBL25431550 0.78 GLS (0.36) LMNAHTTCREBBPALDH1A1L3MBTL1
SCHEMBL31339790 0.78 GLS (0.36) LMNAHTTCREBBPALDH1A1L3MBTL1
SCHEMBL31500757 0.78 L3MBTL1 (0.36) MAPTLMNAKDM4ENPSR1MEN1
SCHEMBL30410440 0.78 TDP1 (0.50) MAPTLMNAHTTKDM4ECREBBP
SCHEMBL618730 0.78 TDP1 (0.50) MAPTLMNAHTTKDM4ECREBBP
SCHEMBL31479973 0.77 MAPT (0.36) MAPTLMNAHTTCREBBPMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10745388-B2 Indazole compounds and uses thereof INCYTE CORPORATION (US) 2020-08-18 US disclosed
US-10745388-B2 Indazole compounds and uses thereof INCYTE CORPORATION (US) 2020-08-18 US disclosed
US-20190256500-A1 INDAZOLE COMPOUNDS AND USES THEREOF INCYTE CORPORATION 2019-08-22 US disclosed
US-20190256500-A1 INDAZOLE COMPOUNDS AND USES THEREOF INCYTE CORPORATION 2019-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10745388-B2 Indazole compounds and uses thereof PDXK, PPIP5K2, PCK1 MAPT 3880/4885LMNA 2392/4885HTT 2736/4885
US-20190256500-A1 INDAZOLE COMPOUNDS AND USES THEREOF PDXK, PPIP5K2, PCK1 MAPT 3880/4885LMNA 2392/4885HTT 2736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.